KRAS and lung cancer: Importantly, WEE1 knockdown suppressed the growth of KRAS-mutated lung cancer cells with TP53 mutations while having a minimal effect on TP53 wild-type KRAS-mutated NSCLC cell lines (Figures 1E–1G).